US Patent 8012465 Methods for treating renal cell carcinoma
Patent 8012465 was granted and assigned to Novartis on September, 2011 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 28, 2009
Date of Patent
September 6, 2011
Patent Application Number
12460991
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8012465 Methods for treating renal cell carcinoma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
